|
Aurobindo Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
91749.23 Cr.
|
P/BV
|
2.42
|
Book Value (Rs.)
|
652.39
|
|
52 Week High/Low (Rs.)
|
1637/1016
|
FV/ML
|
1/1
|
P/E(X)
|
26.18
|
|
Bookclosure
|
17/04/2026
|
EPS (Rs.)
|
60.34
|
Div Yield (%)
|
0.25
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 33384.74 | 31378.13 | 28704.50 | 24617.13 | 23366.55 |
| Other Operating Revenues | 268.34 | 345.60 | 297.37 | 238.25 | 88.94 |
| Total Operating Revenues | 33653.08 | 31723.73 | 29001.87 | 24855.38 | 23455.49 |
| | | | | | |
| Other Income | 492.09 | 621.85 | 557.38 | 290.59 | 320.35 |
| Total Revenue | 34145.17 | 32345.58 | 29559.25 | 25145.97 | 23775.84 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 10305.19 | 10736.76 | 10776.14 | 9652.51 | 7371.83 |
| Purchase Of Stock-In Trade | 3477.98 | 2887.11 | 2772.93 | 2050.43 | 1951.77 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -294.81 | -597.63 | -946.17 | -409.68 | 816.68 |
| Employee Benefit Expenses | 5190.17 | 4475.62 | 3922.94 | 3522.25 | 3450.92 |
| Finance Costs | 383.97 | 457.24 | 289.71 | 140.48 | 48.64 |
| Depreciation And Amortisation Expenses | 1778.19 | 1649.42 | 1521.66 | 1244.58 | 1126.52 |
| Other Expenses | 8128.82 | 7639.08 | 6633.03 | 6321.23 | 5477.52 |
| Total Expenses | 28969.51 | 27247.60 | 24970.24 | 22521.80 | 20243.88 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5175.66 | 5097.98 | 4589.01 | 2624.17 | 3531.96 |
| | | | | | |
| Exceptional Items | -65.33 | 0.00 | -191.86 | 0.00 | -127.97 |
| Profit/Loss Before Tax | 5110.33 | 5097.98 | 4397.15 | 2624.17 | 3403.99 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 1608.88 | 1699.98 | 1777.54 | 1071.48 | 662.82 |
| Deferred Tax | 0.00 | -117.26 | -566.52 | -386.63 | 62.81 |
| Total Tax Expenses | 1608.88 | 1582.72 | 1211.02 | 684.85 | 725.63 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 3501.45 | 3515.26 | 3186.13 | 1939.32 | 2678.36 |
| | | | | | |
| Profit/Loss From Continuing Operations | 3501.45 | 3515.26 | 3186.13 | 1939.32 | 2678.36 |
| | | | | | |
| Profit/Loss For The Period | 3501.45 | 3515.26 | 3186.13 | 1939.32 | 2678.36 |
| | | | | | |
| Minority Interest | 1.78 | 2.31 | 4.00 | -0.15 | 1.04 |
| Share Of Profit/Loss Of Associates | 1.52 | -31.69 | -17.16 | -11.67 | -31.25 |
| Consolidated Profit/Loss After MI And Associates | 3504.75 | 3485.88 | 3172.97 | 1927.50 | 2648.15 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 60.34 | 59.81 | 54.16 | 32.90 | 45.19 |
| Diluted EPS (Rs.) | 60.34 | 59.81 | 54.16 | 32.90 | 45.19 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 439.45 | 263.67 |
